Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. (Q47883450)

6 February 2018

title

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. (English)

1 reference

6 February 2018

1 reference

22

1 reference

6 February 2018

Dipak Kotecha

Dipak Kotecha

1

0 references

Lluis Mont

Lluís Mont

39

0 references

Paulus Kirchhof

Paulus Kirchhof

64

0 references

Anders Ahlsson

Anders Ahlsson

6

0 references

Gregory Lip

4

Gregory Y H Lip

1 reference

6 February 2018

36

Ulf Landmesser

1 reference

6 February 2018

8

Dan Atar

1 reference

PubMed ID

29300976

Carina Blomström-Lundqvist

6 February 2018

12

Carina Blomstrom-Lundqvist

1 reference

6 February 2018

63

Gerhard Hindricks

1 reference

6 February 2018

9

Angelo Auricchio

1 reference

6 February 2018

16

Hugh Calkins

1 reference

6 February 2018

10

Jeroen Bax

1 reference

6 February 2018

2

Günter Breithardt

1 reference

6 February 2018

Martin Borggrefe

13

Martin Borggrefe

1 reference

6 February 2018

Isabelle C Van Gelder

55

Isabelle C Van Gelder

1 reference

6 February 2018

Ben Freedman

24

Ben Freedman

1 reference

6 February 2018

Tatjana S Potpara

46

Tatjana Potpara

1 reference

6 February 2018

Deirdre A Lane

37

Deirdre A Lane

1 reference

6 February 2018

Irina Savelieva

50

Irina Savelieva

1 reference

6 February 2018

Andreas Goette

26

Andreas Goette

1 reference

6 February 2018

Giuseppe Boriani

14

Giuseppe Boriani

1 reference

6 February 2018

Jonas Oldgren

43

Jonas Oldgren

1 reference

6 February 2018

Hein Heidbuchel

31

Hein Heidbuchel

1 reference

6 February 2018

Ulrich Schotten

5

Ulrich Schotten

1 reference

6 February 2018

Renate B. Schnabel

51

Renate Schnabel

1 reference

6 February 2018

Harry J. G. M. Crijns

20

Harry Crijns

1 reference

6 February 2018

Michiel Rienstra

49

Michiel Rienstra

1 reference

6 February 2018

Dobromir Dobrev

21

Dobromir Dobrev

1 reference

6 February 2018

A. John Camm

3

A John Camm

1 reference

6 February 2018

Thorsten Lewalter

38

Thorsten Lewalter

1 reference

6 February 2018

Jens C Nielsen

41

Jens C Nielsen

1 reference

6 February 2018

Jeroen Hendriks

32

Jeroen Hendriks

1 reference

6 February 2018

Axel Brandes

15

Axel Brandes

1 reference

6 February 2018

Stéphane Hatem

29

Stephane Hatem

1 reference

6 February 2018

Michael Oeff

42

Michael Oeff

1 reference

6 February 2018

Ali Oto

44

Ali Oto

1 reference

6 February 2018

Isabelle Richard-Lordereau

48

Isabelle Richard-Lordereau

1 reference

6 February 2018

Sakis Themistoclakis

54

Sakis Themistoclakis

1 reference

6 February 2018

David Werring

60

David Werring

1 reference

6 February 2018

Karl Georg Haeusler

30

Karl Georg Haeusler

1 reference

6 February 2018

Stefan Kääb

34

Stefan Kääb

1 reference

6 February 2018

Stefanie Kespohl

35

Stefanie Kespohl

1 reference

6 February 2018

Michael Nabauer

40

Michael Nabauer

1 reference

6 February 2018

Moritz F Sinner

52

Moritz F Sinner

1 reference

6 February 2018

Panagiotis E Vardas

56

Panagiotis E Vardas

1 reference

6 February 2018

André Ziegler

62

André Ziegler

1 reference

6 February 2018

Stefano Benussi

11

Stefano Benussi

1 reference

6 February 2018

Winnie Chua

19

Winnie Chua

1 reference

6 February 2018

Reza Wakili

58

Reza Wakili

1 reference

6 February 2018

Doreen Haase

28

Doreen Haase

1 reference

6 February 2018

Manuel Castellà

18

Manuel Castellá

1 reference

6 February 2018

author name string

David Arnar

7

1 reference

6 February 2018

Barbara Casadei

17

1 reference

6 February 2018

Martin Feuring

23

1 reference

6 February 2018

Andrea Gerth

25

1 reference

6 February 2018

Eduard Guasch

27

1 reference

6 February 2018

Craig Hunter

33

1 reference

6 February 2018

Laurent Pison

45

1 reference

6 February 2018

Ursula Ravens

47

1 reference

6 February 2018

Philipp Sommer

53

1 reference

6 February 2018

Atul Verma

57

1 reference

6 February 2018

Evelyn Weber

59

1 reference

6 February 2018

Stephan Willems

61

1 reference

6 February 2018

publication date

2 January 2018

1 reference

6 February 2018

published in

EP Europace

1 reference

6 February 2018

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

volume

20

0 references

page(s)

395-407

0 references

issue

3

0 references

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Screening for atrial fibrillation: sensitivity and specificity of a new methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

PULSE-SMART: Pulse-Based Arrhythmia Discrimination Using a Novel Smartphone Application

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Comparison of Microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Comparison of the Microlife blood pressure monitor with the Omron blood pressure monitor for detecting atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Triage tests for identifying atrial fibrillation in primary care: a diagnostic accuracy study comparing single-lead ECG and modified BP monitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The diagnostic accuracy of the MyDiagnostick to detect atrial fibrillation in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Atrial high-rate episodes and stroke prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Differences and trends in stroke prevention anticoagulation in primary care vs cardiology specialty management of new atrial fibrillation: The Retrospective Evaluation and Assessment of Therapies in AF (TREAT-AF) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Predictors and prognostic implications of incident heart failure following the first diagnosis of atrial fibrillation in patients with structurally normal hearts: the Belgrade Atrial Fibrillation Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The Role of Cardiovascular Implantable Electronic Devices in the Detection and Treatment of Subclinical Atrial Fibrillation: A Review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Temporal relationship between subclinical atrial fibrillation and embolic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

An Integrated Management Approach to Atrial Fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Application of Biomarkers for Risk Stratification in Patients with Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Comparison of the ATRIA, CHADS2, and CHA2DS2-VASc stroke risk scores in predicting ischaemic stroke in a large Swedish cohort of patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation: A Subanalysis of the ENGAGE AF-TIMI 48 Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Catheter ablation of atrial fibrillation is associated with reduced risk of stroke and mortality: A propensity score-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Exploring the Potential Benefits and Risks of Anticoagulation for Atrial Fibrillation During Hospitalization for Sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Incidence, Predictors, and Outcomes of New-Onset Atrial Fibrillation in Critically Ill Patients with Sepsis. A Cohort Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Long-term outcomes of secondary atrial fibrillation in the community: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Variation in restarting antithrombotic drugs at hospital discharge after intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Brain MRI to personalise atrial fibrillation therapy: current evidence and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

A review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Rate control in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Lenient versus strict rate control in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Patient-Reported Outcomes for Quality of Life Assessment in Atrial Fibrillation: A Systematic Review of Measurement Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Approaches to catheter ablation for persistent atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Cryoballoon vs. radiofrequency ablation for paroxysmal atrial fibrillation: an updated meta-analysis of randomized and observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

PITX2 Modulates Atrial Membrane Potential and the Antiarrhythmic Effects of Sodium-Channel Blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Lone Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persists Despite Successful Catheter Ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The APPLE score: a novel and simple score for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Left atrial size and function: role in prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Atrial Fibrillation Complexity Parameters Derived From Surface ECGs Predict Procedural Outcome and Long-Term Follow-Up of Stepwise Catheter Ablation for Atrial Fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Global left atrial strain in the prediction of sinus rhythm maintenance after catheter ablation for atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Atrial fibrillation from the pathologist's perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Structural remodeling in atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUX318

21 January 2018

Identifiers

DOI

10.1093/EUROPACE/EUX318

1 reference

6 February 2018

PubMed ID

29300976

1 reference

6 February 2018